The global renal denervation devices market size was valued at US$ 903.9 million in 2023 and is expected to reach US$ 2,332.1 million by 2030, at a CAGR of 14.5% from 2023 to 2030. Renal denervation is a minimally invasive, investigational procedure to treat hypertension (high blood pressure) that has not improved with other treatments. This type of hypertension is called resistant hypertension.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients